Evidence map›Paper›PMID 27387019›Full record

Observational studyBMC cardiovascular disorders2016

High circulating osteoprotegerin levels are associated with non-zero blood groups.

Elod Erno Nagy, Timea Varga-Fekete, Attila Puskas, Piroska Kelemen, Zoltan Brassai, Katalin Szekeres-Csiki, Timea Gombos, Maria Csilla Csanyi, Jolan Harsfalvi

Open access · goldAbstract readComparative StudyObservational Study
In one paragraph

Observational study in BMC cardiovascular disorders, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Elevated Plasma von Willebrand Factor Antigen and Activity Levels Are Associated With the Severity of Coronary Stenosis.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Elod Erno NagyDepartment of Pharmaceutical Biochemistry, University of Medicine and Pharmacy, Targu-Mures, Romania.
Timea Varga-FeketeIInd Clinic of Internal Medicine, University of Medicine and Pharmacy, Targu-Mures, Romania.
Attila PuskasIInd Clinic of Internal Medicine, University of Medicine and Pharmacy, Targu-Mures, Romania.
Piroska KelemenIInd Clinic of Internal Medicine, University of Medicine and Pharmacy, Targu-Mures, Romania.
Zoltan BrassaiIInd Clinic of Internal Medicine, University of Medicine and Pharmacy, Targu-Mures, Romania.
Katalin Szekeres-CsikiClinical Research Centre, University of Debrecen, Debrecen, Hungary.
Timea GombosIIIrd Department of Internal Medicine, Semmelweis University Budapest, Budapest, Hungary.
Maria Csilla CsanyiDepartment of Biophysics and Radiation Biology, Semmelweis University Budapest, Faculty of Medicine, H-1444, Budapest, P.O.B. 263, Hungary.
Jolan HarsfalviDepartment of Biophysics and Radiation Biology, Semmelweis University Budapest, Faculty of Medicine, H-1444, Budapest, P.O.B. 263, Hungary. harsfalvi.jolan@med.semmelweis-univ.hu.
Semmelweis University · HUUniversitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · ROSpitalul Clinic Judetean de Urgenta Târgu Mureş · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoprotegerin (OPG) and von Willebrand factor (VWF) form complex within endothelial cells and following secretion. The nature of blood group antigens strongly influences the levels of circulating VWF, but there is no available data concerning its ascendancy on OPG levels. We aimed to assess the relationship of AB0 blood groups with OPG, VWF levels (VWF: Ag) and collagen binding activity (VWF: CB) in peripheral arterial disease (PAD) patients.

methodsFunctional and laboratory parameters of 105 PAD patients and 109 controls were examined. Results of OPG, VWF: Ag, VWF: CB (ELISA-s) were analysed by comparative statistics, together with clinical data.

resultsOPG levels were higher in patients than in controls (4.64 ng/mL vs. 3.68 ng/mL, p < 0.001). Among patients elevation was marked in the presence of critical limb ischemia (5.19 ng/mL vs. 4.20 ng/mL, p = 0.011). The OPG in patients correlated positively with VWF: Ag and VWF: CB (r = 0.26, p = 0.008; r = 0.33, p = 0.001) and negatively with ankle-brachial pressure index (r = -0.22, p = 0.023). Furthermore, OPG was significantly elevated in non-0 blood groups compared to 0-groups both in patients and controls (4.95 ng/mL vs. 3.90 ng/mL, p = 0.012 and 4.09 ng/mL vs. 3.40 ng/mL, p = 0.002).

conclusionsOPG levels are associated to blood group phenotypes and higher in non-0 individuals. Increased OPG levels in PAD characterize disease severity. The significant correlation between OPG and VWF:CB might have functional importance in an atherothrombosis-prone biological environment.

Indexed as

ABO Blood-Group SystemBiomarkersEnzyme-Linked Immunosorbent AssayFemaleHumansIncidenceMaleMiddle AgedOsteoprotegerinPeripheral Arterial DiseasePhenotypeRisk FactorsRomaniaSeverity of Illness IndexUltrasonography, Doppler, DuplexABO Blood-Group SystemBiomarkersOsteoprotegerinAB0 blood groupsAtherosclerosisCritical ischemiaDiabetesEndothelial dysfunctionHypertensionOsteoprotegerinPeripheral arterial diseaseVon Willebrand factor

Identifiers

PMID27387019
PMCPMC4937555
OpenAlexW2395884327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.